Dispelling myths about acne

Postgraduate Medicine

Volumn 102, Issue 2, 1997, Pages 94-112

  Landow, Ken ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADAPALENE; ANTIINFLAMMATORY AGENT; AZELAIC ACID; BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE; CLOFAZIMINE; CORTICOSTEROID; COTRIMOXAZOLE; CYPROTERONE ACETATE; DANAZOL; DANTROLENE; DOXYCYCLINE; ERYTHROMYCIN; FINASTERIDE; FLUTAMIDE; HALOGEN; HALOPERIDOL; ISONIAZID; ISOTRETINOIN; LEVONORGESTREL; LITHIUM; LUGOL; MINOCYCLINE; PHENYTOIN; RETINOIC ACID; RIFAMPICIN; SPIRONOLACTONE; TETRACYCLINE; TRAZODONE; UNINDEXED DRUG;

ACNE; CHEILITIS; DRUG COST; DRUG FORMULATION; FETUS MALFORMATION; HUMAN; INFLAMMATION; ORAL DRUG ADMINISTRATION; PATIENT EDUCATION; PROPIONIBACTERIUM ACNES; PRURITUS; REVIEW; SEBACEOUS GLAND; SKIN IRRITATION; TOPICAL DRUG ADMINISTRATION; XEROSIS;

EID: 0030791132     PISSN: 00325481     EISSN: None     Source Type: Journal    
DOI: 10.3810/pgm.1997.08.287     Document Type: Review

References (33)

1. Stern RS. The prevalence of acne on the basis of physical examination. J Am Acad Dermatol 1992;26(6):931-5
2. Webster GF. Inflammation in acne vulgaris. J Am Acad Dermatol 1995;33(2 Pt 1):247-53
3. Leyden JJ. New understandings of the pathogenesis of acne. J Am Acad Dermatol 1995;32(5 Pt 3):15-25S
4. Cargnello JA. Acne: what's new? Med J Aust 1996;165(3):153-8
5. Kaminer MS, Gilchrest BA. The many faces of acne. J Am Acad Dermatol 1995;32(5 Pt 3):6-14S
6. Lucky AW, Biro FM, Huster GA, et al. Acne vulgaris in premenarchal girls: an early sign of puberty associated with rising levels of dehydroepiandrosterone. Arch Dermatol 1994;130(3):308-14
7. Hurwitz S. Acne vulgaris: pathogenesis and management. Pediatr Rev 1994;15(2):47-52
8. Ives TJ. Benzoyl peroxide. Am Pharm 1992;NS32(8):33-8
9. Gibson JR. Rationale for the development of new topical treatments for acne vulgaris. Cutis 1996;57(1 Suppl):13-9
10. Thiboutot DM. An overview of acne and its treatment. Cutis 1996;57(1 Suppl):8-12
11. Plewig G, Kligman AM. Acne and rosacea. 2d ed. New York: Springer-Verlag, 1993:584-8
12. Rothman KF, Lucky AW. Acne vulgaris. Adv Dermatol 1993:8:347-75
13. Shalita A, Weiss JS, Chalker DK, et al. A comparison of the efficacy and safety of adapalene gel 0.1% and tretinoin gel 0.025% in the treatment of acne vulgaris: a multicenter trial. J Am Acad Dermatol 1996;34(3):482-5
14. 11 PP 599-602
15. Graupe K, Cunliffe WJ, Gollnick HP, et al. Efficacy and safety of topical azelaic acid (20 percent cream): an overview of results from European clinical trials and experimental reports. Cutis 1996; 57(1 Suppl):20-35
16. Fitton A, Goa KL. Azelaic acid: a review of its pharmacological properties and therapeutic efficacy in acne and hyperpigmentary skin disorders. Drugs 1991;41(5):780-98
17. Gardner KJ, Cunliffe WJ, Eady EA, et al. Variation in comedonal antibiotic concentrations following application of topical tetracycline for acne vulgaris. Br J Dermatol 1994;131(5):649-54
18. Oakley A, Rademaker M, Duffill M, et al. Propionibacterium: resistance of acne to antibiotics. (Letter) N Z Med J 1995;108(993):43-4
19. 11 pp 611-3
20. Layton AM, Hughes BR, Hull SM, et al. Seborrhoea: an indicator for poor clinical response in acne patients treated with antibiotics. Clin Exp Dermatol 1992;17(3):173-5
21. Eady EA, Jones CE, Gardner KJ, et al. Tetracycline-resistant propionibacteria from acne patients are cross-resistant to doxycycline, but sensitive to minocycline. Br J Dermatol 1993;128(5):556-60
22. Eady EA, Jones CE, Tipper JL, et al. Antibiotic resistant propionibacteria in acne: need for policies to modify antibiotic usage. BMJ 1993;306(6877);555-6
23. Driscoll MS, Rothe MJ, Abrahamian L, et al. Long-term oral antibiotics for acne: is laboratory monitoring necessary? J Am Acad Dermatol 1993;28(4):595-602
24. Murphy AA, Zacur HA, Charache P, et al. The effect of tetracycline on levels of oral contraceptives. Am J Obstet Gynecol 1991-,164(1 Pt 1):28-33
25. Neely JL, Abate M, Swinker M, et al. The effect of doxycycline on serum levels of ethinyl estradiol, norethindrone, and endogenous progesterone. Obstet Gynecol 1991;77(3):416-20
26. Miller DM, Helms SE, Brodell RT. A practical approach to antibiotic treatment in women taking oral contraceptives. J Am Acad Dermatol 1994;30(6):1008-11
27. Kaplan B. Desogestrel, norgestimate, and gestodene: the newer progestins. Ann Pharmacother 1995;29(7-8):736-42
28. 11 pp 662-9
29. 11 pp 625-7
30. Goulden V, Layton AM, Cunliffe WJ. Current indications for isotretinoin as a treatment for acne vulgaris. Dermatology 1995;190(4):284-7
31. Harms M. Isotretinoin: 10 years on. (Editorial) Dermatology 1993;186(2):81-2
32. Layton AM, Cunliffe WJ. Guidelines for optimal use of isotretinoin in acne. J Am Acad Dermatol 1992;27(6 Pt 2):2-7S
33. Barth JH, Macdonald-Hull SP, Mark J, et al. Isotretinoin therapy for acne vulgaris: a re-evaluation of the need for measurements of plasma lipids and liver function tests. Br J Dermatol 1993;129(6):704-7